Journal article
Four‐year results of a minimally invasive transscleral glaucoma gel stent implantation in a prospective multi‐centre study
Abstract
IMPORTANCE: The transscleral XEN Glaucoma Gel Microstent (XEN-GGM, Allergan Plc., Parsippany, New Jersey) is implanted by a minimally invasive ab interno technique.
BACKGROUND: The present study aims to assess the long-term clinical outcomes in patients after XEN-GGM implantation.
Authors
Lenzhofer M; Kersten‐Gomez I; Sheybani A; Gulamhusein H; Strohmaier C; Hohensinn M; Dick HB; Hitzl W; Eisenkopf L; Sedarous F
Journal
Clinical and Experimental Ophthalmology, Vol. 47, No. 5, pp. 581–587
Publisher
Wiley
Publication Date
7 2019
DOI
10.1111/ceo.13463
ISSN
1442-6404
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AdolescentAdultAgedAged, 80 and overCataract ExtractionFemaleGlaucoma Drainage ImplantsGlaucoma, Open-AngleHumansIntraocular PressureMaleMiddle AgedMinimally Invasive Surgical ProceduresProspective StudiesProsthesis ImplantationStentsTonometry, OcularTreatment OutcomeVisual AcuityVisual FieldsYoung Adult